• No results found

Original Article Bufalin combined with hydroxycamptothecin affect in vitro cell growth and apoptosis of human Du145 prostate cancer cells

N/A
N/A
Protected

Academic year: 2020

Share "Original Article Bufalin combined with hydroxycamptothecin affect in vitro cell growth and apoptosis of human Du145 prostate cancer cells"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1. Growth inhibition rates of prostate cancer Du145 cells after admin-istration of indicated bufalin or HCPT concentrations for 24 h or 48 h, *P < 0.05 significant difference between indicated concentration bufalin or HCPT and 0.0001 nmol/L bufalin or HCPT for 24 h, #P < 0.05 significant difference between indicated concentration bufalin or HCPT and 0.0001 nmol/L bufalin or HCPT for 48 h.
Table 1. Effect of combined use of bufalin and HCPT for 24 h on prostate cancer Du145 cell growth inhibition (%)
Figure 2. Flow cytometer analyses of Du145 prostate cancer cell cycle chang-es after treatment with 0.01 nmol/L bufalin or 0.01 µgr/ml HCPT for 24 hours
Figure 4. The protein expression Caspase 3 in Du145 cells after single or combined use of indicated bufalin and HCPT concentrations for 24 h.

References

Related documents

In this study, we have used human hormone-resistant prostate cancer cells, DU145 and PC3, as an in vitro model to assess the efficacy of xanthohumol (XN) against cell growth,

Moreover, our findings demonstrate that miR-181a inhibition enhanced apoptosis in cisplatin resistant prostate cancer cells and restored BAX expression; these observations

A and B: Inhibition on lncRNA CCAT1 promoted the protein expression of apoptotic protein Bax, caspase 3 and caspase 9, and reduced the level of Bcl-2 in colon cancer cell SW620

The expression levels of CCR7 in pros- tate cancer cells transfected with siRNA were decreased, leading to a significant inhibition of prostate cancer cell proliferation, migration

Abstract: Prostate cancer, one of the most lethal forms of urinary system cancer, remains resistant to currently available treatments. Therefore, novel mechanism and

XB130 mRNA (Figure 2A) and protein (Figure 2B) levels were detected in prostate cancer cell line 22RV1, LNCap, DU145, PC3, which showed that XB130 expressed in four

Summary of cytotoxicity data for 4 human prostate cell lines (“normal”: 1542N; cancer: DU145, LNCaP; benign prostate.. hyperplasia: BPH - 1) and relative radiosensitivity determined

In summary, klotho, a potential tumor suppressor, can inhibit the growth of lung cancer cells A549 and promote their apoptosis, this may be partly due to the inhibition of